-
1دورية أكاديمية
المؤلفون: Clamp, AR, James, EC, McNeish, IA, Dean, A, Kim, J-W, O'Donnell, DM, Gallardo-Rincon, D, Blagden, S, Brenton, J, Perren, TJ, Sundar, S, Lord, R, Dark, G, Hall, M, Banerjee, S, Glasspool, RM, Hanna, CL, Williams, S, Scatchard, KM, Nam, H, Essapen, S, Parkinson, C, McAvan, L, Swart, AM, Popoola, B, Schiavone, F, Badrock, J, Fananapazir, F, Cook, AD, Parmar, M, Kaplan, R, Ledermann, JA
المساهمون: Banerjee, Susana
مصطلحات موضوعية: Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Ovarian Epithelial, Fallopian Tubes, Female, Humans, Middle Aged, Ovarian Neoplasms, Paclitaxel
جغرافية الموضوع: England
وصف الملف: Print-Electronic; 930; application/pdf
العلاقة: S1470-2045(22)00283-2; The Lancet Oncology, 2022, 23 (7), pp. 919 - 930; https://repository.icr.ac.uk/handle/internal/5475Test
الإتاحة: https://doi.org/10.1016/S1470-2045Test(22)00283-2
https://repository.icr.ac.uk/handle/internal/5475Test -
2
المؤلفون: Oza, AM, Cook, AD, Pfisterer, J, Embleton, A, Ledermann, JA, Pujade-Lauraine, E, Kristensen, G, Carey, MS, Beale, P, Cervantes, A, Park-Simon, T-W, Rustin, G, Joly, F, Mirza, MR, Plante, M, Quinn, M, Poveda, A, Jayson, GC, Stark, D, Swart, AM, Farrelly, L, Kaplan, R, Parmar, MKB, Perren, TJ
المصدر: Oza, A M, Cook, A D, Pfisterer, J, Embleton, A, Ledermann, J A, Pujade-Lauraine, E, Kristensen, G, Carey, M S, Beale, P, Cervantes, A, Park-Simon, T-W, Rustin, G, Joly, F, Mirza, M R, Plante, M, Quinn, M S, Poveda, A, Jayson, G C, Stark, D, Swart, A M, Farrelly, L, Kaplan, R, Parmar, M K B, Perren, T J & ICON7 trial investigators 2015, ' Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7) : overall survival results of a phase 3 randomised trial ', Lancet Oncology, vol. 16, no. 8, pp. 928-936 . https://doi.org/10.1016/S1470-2045Test(15)00086-8
مصطلحات موضوعية: Canada, Time Factors, Paclitaxel, Clinical Trial, Phase III, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Drug Administration Schedule, Carboplatin, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Humans, Infusions, Intravenous, Neoplasm Staging, Ovarian Neoplasms, Research Support, Non-U.S. Gov't, Australia, Survival Analysis, Intention to Treat Analysis, Bevacizumab, Europe, Multicenter Study, Treatment Outcome, Oncology, Randomized Controlled Trial, Disease Progression, Female, Neoplasm Grading, New Zealand
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8dee481155bef518cb7d7907f28f5f8fTest
https://vbn.aau.dk/da/publications/eb7eb733-cabd-47b8-b97c-4c9966777fa3Test -
3
المؤلفون: Durbecq, V., Paesmans, M., Cardoso, F., Desmedt, C., Di Leo, A., Chan, S., Friedrich, K., Pinter, T., Belle, S., Murray, E., Bodrogi, I., Euan Walpole, Lesperance, B., Korec, S., Crown, J., Simmonds, P., Perren, Tj, Leroy, Jy, Rouas, G., Sotiriou, C., Piccart, M., Larsimont, D.
المصدر: ResearcherID
مصطلحات موضوعية: Adult, Receptor, ErbB-2, Breast Neoplasms, Docetaxel, Middle Aged, Immunohistochemistry, DNA-Binding Proteins, DNA Topoisomerases, Type II, Treatment Outcome, Antigens, Neoplasm, Doxorubicin, Cell Line, Tumor, Multivariate Analysis, Biomarkers, Tumor, Odds Ratio, Humans, Female, Taxoids, Poly-ADP-Ribose Binding Proteins, Aged, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b6e36acb2208baa05fe5960287c64c14Test
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000224488400004&KeyUID=WOS:000224488400004Test
